Posted On April 4, 2021
At 34, Vivek Ramaswamy, founder and CEO of Roivant Sciences, is already a top leader in biotech. In Roivant, he has created a unique company comprising smaller units that together boast more that 45 investigational drugs in 14 therapeutic areas. Here, he shares his (somewhat provocative) thoughts on the responsibilities of corporations in times of crisis.
The conversation is part of an ongoing series of Vanguard Dialogues with top leaders about "Leading Through Uncertainty."